Cargando…
Direct Effects of Mifepristone on Mice Embryogenesis: An In Vitro Evaluation by Single-Embryo RNA Sequencing Analysis
The clinical use of mifepristone for medical abortions has been established in 1987 in France and since 2000 in the United States. Mifepristone has a limited medical period that lasts <9 weeks of gestation, and the incidence of mifepristone treatment failure increases with gestation time. Mifepri...
Autores principales: | Su, Yu-Ting, Chen, Jia-Shing, Lan, Kuo-Chung, Lee, Yung-Kuo, Chu, Tian-Huei, Ho, Yu-Cheng, Wu, Cheng-Chun, Huang, Fu-Jen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046204/ https://www.ncbi.nlm.nih.gov/pubmed/36979886 http://dx.doi.org/10.3390/biomedicines11030907 |
Ejemplares similares
-
Mifepristone Directly Disrupts Mouse Embryonic Development in Terms of Cellular Proliferation and Maturation In Vitro
por: Su, Yu-Ting, et al.
Publicado: (2021) -
In vitro genotoxicity assessment and 28-day repeated dose oral toxicity study of steady-calcium formula in rats
por: Chang, Ting-Yu, et al.
Publicado: (2022) -
Disposition of embryos from women who only produced morphologically poor embryos on day three
por: Lin, Pin-Yao, et al.
Publicado: (2022) -
HDAC1 is Involved in Neuroinflammation and Blood-Brain Barrier Damage in Stroke Pathogenesis
por: Wang, Hao-Kuang, et al.
Publicado: (2023) -
Hysteroscopic cervical features associated with difficult embryo transfer in unselected patients undergoing in vitro fertilization
por: Ou, Yu-Che, et al.
Publicado: (2022)